Arvind Dasari

Arvind Dasari at MD Anderson has contributed to understanding the epidemiology of neuroendocrine tumors in the United States through SEER database analyses. His work documenting the rising incidence of NETs across all primary sites and stages, and his analyses of survival trends, has quantified the growing clinical burden of neuroendocrine tumors and demonstrated improving outcomes over time attributable to better treatment options.